feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Shingles Vaccine Linked to Healthier Aging

Shingles Vaccine Linked to Healthier Aging

21 Jan

•

Summary

  • Shingles vaccination is associated with reduced biological aging signs.
  • Vaccinated individuals showed less inflammation and slower aging.
  • The vaccine may support healthier aging by reducing inflammation.
Shingles Vaccine Linked to Healthier Aging

A recent study involving over 3,800 individuals indicates that the shingles vaccination may contribute to healthier aging. The research observed that vaccinated participants showed diminished signs of biological aging and inflammation.

These findings suggest that the vaccine could potentially slow age-related decline by reducing background inflammation. This mechanism might be linked to preventing the reactivation of the virus that causes shingles.

The study measured seven aspects of biological aging, including inflammation, immune response, and epigenetic aging. Participants who received the shingles jab demonstrated significantly lower inflammation levels and slower epigenetic and transcriptomic aging.

trending

Strong solar radiation storm reaches Earth

trending

Adani Power NCLAT approval

trending

JEE Main 2026 Exam

trending

MCX gold hits record high

trending

Kalyan Jewellers share price crashes

trending

RCB leads WPL points table

trending

Natural gas price jumps sharply

trending

Nifty Equal Weight outperforms

trending

Delhi Capitals jump to 4th

These results align with emerging evidence connecting adult vaccines, such as those for shingles and influenza, with reduced risks of dementia and neurodegenerative disorders. The research highlights the potential for vaccines to modulate biological systems beyond merely preventing infection, thereby promoting resilience and supporting healthy aging strategies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The shingles vaccine may help reduce biological aging and inflammation, contributing to overall healthier aging.
The vaccine may help reduce background inflammation, which is a known contributor to various age-related conditions.
The shingles vaccine is available on the NHS for adults turning 65 and those aged between 70 and 79 years old.

Read more news on

Healthside-arrow

You may also like

Flu Deaths Climb: 32 Children Lost, Most Unvaccinated

1 day ago • 23 reads

article image

Winter Rash? Shingles Cases Surge 50%

12 Jan • 3 reads

article image

Vaccines May Slash Dementia Risk, Study Shows

7 Jan • 118 reads

article image

COVID Booster May Slightly Raise Shingles Risk

19 Dec, 2025 • 170 reads

article image

B.C. ERs Overwhelmed: Parents Urged to Vaccinate Amidst Flu Surge

17 Dec, 2025 • 182 reads